Dow Up 0.64% Nasdaq Up 0.68%

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
5.22 Down 0.10(1.88%) 4:00PM EDT
|After Hours : 5.22 0.00 (0.00%) 5:11PM EDT
Prev Close:5.32
Open:5.39
Bid:5.19 x 100
Ask:5.35 x 2000
1y Target Est:9.50
Beta:1.41
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.16 - 5.42
52wk Range:3.10 - 7.45
Volume:641,644
Avg Vol (3m):1,416,020
Market Cap:363.08M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXDown 1.88%363.08M
DNDNDown 4.05%220.71M
NKTRDown 2.62%1.70B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):51.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.99

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback